
Live Regeneron Pharmaceuticals Tokenized Stock (Ondo) price
Regeneron Pharmaceuticals Tokenized Stock (Ondo) price chart
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) price details

Regeneron Pharmaceuticals Tokenized Stock (Ondo) price history
Regeneron Pharmaceuticals Tokenized Stock (Ondo) technical analysis

Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) sentiment
About Regeneron Pharmaceuticals Tokenized Stock (Ondo)
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) Introduction
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) represents a tokenized version of Regeneron Pharmaceuticals' stock, ticker REGN, on the blockchain. As per CoinMarketCap data extracted on March 31, 2026, its live price stands at $745.53 USD, with a 24-hour trading volume of $33,575.65 USD and a slight 0.92% decline. The token's market cap is $109.54 USD, with a circulating supply of about 0.147 REGNON coins and no maximum supply defined. Ranked #3719 on CoinMarketCap, REGNON offers synthetic exposure to Regeneron's performance in biotech, focusing on treatments for diseases like COVID-19 and eye conditions. Ondo Finance powers this by tokenizing assets, making them accessible globally via Ethereum, as seen on Etherscan. This setup appeals to crypto enthusiasts seeking diversified portfolios without traditional barriers.
How does Regeneron Pharmaceuticals Tokenized Stock (Ondo) Crypto Work?
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) operates through Ondo Finance's tokenization protocol on the Ethereum blockchain. Users mint REGNON by depositing collateral, gaining exposure to REGN stock's price and dividends, which are automatically reinvested. This synthetic asset mirrors REGN's performance via smart contracts, ensuring 24/5 liquidity from traditional exchanges. As explained in Ondo Finance's documentation, restrictions apply to US persons for regulatory compliance. The token's value tracks Regeneron's stock, influenced by biotech innovations like monoclonal antibodies. Blockchain explorers like Etherscan verify transactions, promoting transparency. Unlike direct stock ownership, REGNON avoids voting rights but offers crypto advantages like fast settlements. Critics note potential oracle risks for price feeds, yet Ondo's secure design, audited by firms like PeckShield, addresses these, making it a reliable RWA tool.
Regeneron Pharmaceuticals Tokenized Stock (Ondo) (token ticker REGNON) Price Prediction
Forecasting the price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) involves analyzing its tie to REGN stock and broader market trends. Current data from CoinMarketCap shows REGNON at $745.53 USD, down 0.92% in 24 hours, reflecting biotech sector fluctuations. Analysts like those at Seeking Alpha predict REGN could rise 15-20% in 2026, driven by pipeline drugs, potentially boosting REGNON similarly. However, crypto volatility adds risks. For a detailed Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) price prediction and forecast, visit WEEX to explore current data and future outlooks. Remember, predictions aren't guarantees; factors like regulatory changes or market downturns could impact values.
How Do You Buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) (Abbreviation REGNON)?
Buying Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNON) starts with selecting a reliable exchange. First, register on WEEX or log in on WEEX if you have an account. Once set up, deposit funds like USDT. Search for the REGNON/USDT pair and place a buy order at market or limit price. For step-by-step guidance, check out this how to buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) guide on WEEX. Always verify wallet compatibility with Ethereum, as REGNON is ERC-20. Don't forget to enable two-factor authentication for security. Start small to understand fees and market dynamics before larger investments.
Official links
Social media and community
FAQ
1. What is the current price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) in USD?
2. What is the market capitalization of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
3. What is the circulating supply of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
4. What factors influence the price of Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
5. Is Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon) a good investment?
6. Where can I buy Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
7. What are the typical fees when buying Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
8. What are some technical indicators used for analyzing Regeneron Pharmaceuticals Tokenized Stock (Ondo) (REGNon)?
Currency price converter
Popular
Global prices
¥
₽
€
$
¥
NT$
₫
aed
₴
zł
R$
Rp
$
₼Regeneron Pharmaceuticals Tokenized Stock (Ondo) news
From Casino Tools to Global Pricing Machines: The NYSE Leader's Perspective on Hyperliquid
"Why can they do it, but we can't?" This rhetorical question not only reveals the anxiety of traditional exchanges but also reflects the subtle and complex game between TradFi and DeFi after perpetual contracts have shifted from being gambling tools to global price discovery infrastructure.
A Detailed Analysis of "Stock God Serenity" Investment Methodology
In the major trend of AI and other areas, instead of buying the most eye-catching popular stocks, we should drill down along the industry chain to find the most irreplaceable bottlenecks in future architectural migrations, and place bets in advance while old financial reports, old valuations, and ol...
Sharplink CEO: The future of Ethereum is unfolding
The market is focused on the ETH price and foundation controversies, but overlooks the bigger picture: Ethereum is far ahead in stablecoin settlement, RWA, and DeFi, and has already met the conditions for institutional adoption.
Morning Report | Korea Investment & Securities and OKX plan to jointly acquire 40% of Coinone; Polymarket denies implementing KYC comprehensively; Grayscale delays U.S. stock IPO plans
Overview of Important Market Events on May 28
Bit Digital CEO: Why I Bought More ETH
Valuation re-evaluation will never come from retail investors' enthusiasm for narratives; for an asset with such a vast underlying infrastructure, that has always been a fragile foundation. The real catalyst is institutional demand, and institutional demand does not operate according to the timeline...
A Decade of Three Waves of Stock Tokenization from Bitget's Reality: An Unfinished Financial Exploration
Reality represents the latest step in this revolution. What the next step is, is not in Bitget's release materials, but in the next 12 to 24 months, on the first day Nasdaq goes live, on the day the SEC's new regulations take effect, and on the day Bitget can obtain a formal financial license in a m...
Website
X(Twitter)











